Fluoroquinolone and macrolide co-resistance in clinical isolates of Campylobacter species: a 15-year study in Karachi, Pakistan
AbstractFluoroquinolone and macrolide antibiotics are generally considered as first-line drugs for the treatment of severe campylobacteriosis. This study was conducted to analyse the trend of erythromycin and ofloxacin resistance among Campyiobacter spp. isolated from stool specimens over a period of 15 years [1992-2007] at The Aga Khan University clinical laboratory in Karachi, Pakistan. A total of 83 396 stool specimens were processed, with a 14% isolation rate for enteric pathogens. The isolation rate of Campylobacter spp. was low during 1992-93 [6%-13%], peaked in 1996 [46%], then ranged from 20% to 40%. We report a rising trend in ofloxacin resistance, re-emergence of erythromycin resistance and indications of co-resistance to both drugs in clinical isolates of Campylobocter spp.
Irfan, S., Ahmad, A., Guhar, D., Khan, E., Malik., F. et al. (2010). Fluoroquinolone and macrolide co-resistance in clinical isolates of Campylobacter species: a 15-year study in Karachi, Pakistan. EMHJ - Eastern Mediterranean Health Journal, 16 (12), 1226-1230, 2010 http://www.who.int/iris/handle/10665/118058
JournalEMHJ - Eastern Mediterranean Health Journal, 16 (12), 1226-1230, 2010
MetadataShow full item record
Showing items related by title and MeSH subject.